热反应性水凝用于肝细胞癌的跨导管动脉化学栓塞

Wei Zhao1, Jiabin Xu1, Yuanyuan You2

  • 1Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China. ozonetherapy@126.com.

Chemical communications (Cambridge, England)
|July 11, 2023
PubMed
概括

一种新的水凝药物递送系统改善了肝癌 (HCC) 的跨动脉化学栓塞 (TACE). 这种稳定的配方降低了全身毒性,在临床前模型中提高了治疗疗效.

相关概念视频